What is Telic?
Telic operates at the intersection of orthopedic health and athletic performance, specializing in recovery footwear designed to mitigate foot pain and support post-training recuperation. By leveraging its proprietary Novalon material, the company delivers a unique value proposition characterized by soft stability and enhanced durability. The brand has successfully carved out a niche by securing doctor recommendations for conditions such as plantar fasciitis, positioning itself as a critical component of the athlete's recovery toolkit. With a commitment to domestic manufacturing, Telic maintains a robust supply chain advantage that appeals to a diverse demographic, ranging from professional athletes to everyday consumers seeking ergonomic comfort.
How much funding has Telic raised?
Telic has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Telic
PPP
Public-Private Partnership
What's next for Telic?
Following this late-stage financing, Telic is well-positioned to accelerate its market penetration and operational efficiency. The strategic deployment of this capital will likely focus on scaling production capabilities to meet rising demand while potentially expanding its retail footprint. As the recovery footwear market continues to mature, Telic's focus on evidence-based design and material innovation will be instrumental in maintaining its competitive edge. Future growth initiatives will likely prioritize brand awareness campaigns and the diversification of its product portfolio to address broader orthopedic needs, ensuring the company remains a leader in the intersection of health-conscious consumer goods and high-performance apparel.
See full Telic company page
